Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Boule Diagnostics

4.04 SEK

-0.74 %

Less than 1K followers

BOUL

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.74 %
-19.84 %
-17.72 %
-31.29 %
-33.77 %
-54.50 %
-69.16 %
-89.55 %
-56.11 %

Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.

Read more
Market cap
156.89M SEK
Turnover
28.73K SEK
Revenue
489.6M
EBIT %
4.55 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/4
2026

Interim report Q1'26

13/5
2026

General meeting '26

17/7
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release2/11/2026, 7:00 AM

Boule Diagnostics bokslutskommuniké 2025

Boule Diagnostics
Regulatory press release2/11/2026, 7:00 AM

Boule Diagnostics Year-end report 2025

Boule Diagnostics
Press release2/6/2026, 9:30 AM

Boule Diagnostics – Inbjudan till presentation av Q4 2025

Boule Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/6/2026, 9:30 AM

Boule Diagnostics – Invitation to presentation of the Q4 report 2025

Boule Diagnostics
Press release1/21/2026, 7:30 AM

Boule Diagnostics förnyar och utökar ett globalt leveransavtal

Boule Diagnostics
Press release1/21/2026, 7:30 AM

Boule Diagnostics Renews and Expands a Global Supply Agreement

Boule Diagnostics
Regulatory press release12/30/2025, 7:30 AM

Boule Diagnostics utser Michael af Winklerfelt till CFO

Boule Diagnostics
Regulatory press release12/30/2025, 7:30 AM

Boule Diagnostics appoints Michael af Winklerfelt as new CFO

Boule Diagnostics
Press release12/22/2025, 10:00 AM

Boule Diagnostics utvald som en av tre leverantörer i den nationella hematologiupphandlingen i Italien

Boule Diagnostics
Press release12/22/2025, 10:00 AM

Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy

Boule Diagnostics
Regulatory press release12/5/2025, 7:25 AM

Boule Diagnostics meddelar att VD lämnar och organisationen förbereder sig för nästa kapitel

Boule Diagnostics
Regulatory press release12/5/2025, 7:25 AM

Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Chapter

Boule Diagnostics
Regulatory press release11/21/2025, 3:00 PM

Boule Diagnostics – Valberedning inför årsstämman 2026

Boule Diagnostics
Regulatory press release11/21/2025, 3:00 PM

Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026

Boule Diagnostics
Regulatory press release10/29/2025, 10:18 AM

Finansinspektionen: Flaggningsmeddelande i Boule Diagnostic AB

Boule Diagnostics
Regulatory press release10/24/2025, 6:00 AM

Boule Diagnostics delårsrapport Q3 2025

Boule Diagnostics
Regulatory press release10/24/2025, 6:00 AM

Boule Diagnostics Interim Report Q3 2025

Boule Diagnostics
Press release10/20/2025, 8:45 AM

BOULE DIAGNOSTICS – INBJUDAN TILL PRESENTATION AV Q3 2025

Boule Diagnostics
Press release10/20/2025, 8:45 AM

Boule Diagnostics – Invitation to presentation of the interim report Q3 2025

Boule Diagnostics
Regulatory press release10/13/2025, 6:35 AM

Boule Diagnostics CFO lämnar för ny möjlighet

Boule Diagnostics
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.